Archive for the ‘Treatment’ Category

FREE: Ross Lyme Support Protocol

https://s3.amazonaws.com/hoth.bizango/assets/24360/Ross_Lyme_Support_Protocol.pdf  Protocol Here

The Ross Lyme Support Protocol

By Dr. Marty Ross

The Ross Lyme Support Protocol includes essential steps to begin and continue a chronic Lyme disease treatment. It is designed to:

● boost the immune system

● improve detoxification

● speed recovery

● kill the infection(s)

● protect and repair from the harmful effects of the infection(s) and the herbal or prescription antibiotics.

While the following Lyme disease treatment approach focuses on a limited number of areas, it may correct most of the problems, such as: low energy, pain, insomnia, brain, neurologic, and thinking problems (brain fog), and immune compromise and suppression.

Table of Key Supplements and Herbs in The Core Protocol

What’s New: Ross Protocol 3rd Edition

________________

For more:

Category:

Detoxing, Gut Health, Herbs, Inflammation, Lyme, Sleep, Supplements, Treatment

Lyme Disease Patients Detail Treatment-Denial Conspiracy at Fifth Circuit

https://www.courthousenews.com/lyme-disease-patients-detail-treatment-denial-conspiracy-at-fifth-circuit/

Lyme disease patients detail treatment-denial conspiracy at Fifth Circuit

Lyme disease sufferers say they had trouble finding doctors willing to treat them due to a scheme to deny care by insurers and infectious disease experts.
 / September 7, 2023

Article Excerpts:

(CN) — A group of Lyme disease patients asked the Fifth Circuit on Thursday to revive their lawsuit against a medical society they claim issued bogus guidelines that insurers used to deny them coverage, forcing some to pay hundreds of thousands of dollars for their care.

Lisa Torrey and 27 others sued the Infectious Diseases Society of America, or IDSA, seven health insurance companies and several medical doctors in 2017 in Texarkana, Texas, federal court.

Bringing RICO Act and antitrust claims, the plaintiffs claim several major health insurers decided treating Lyme disease was too expensive, so they paid IDSA-affiliated doctors to establish arbitrary guidelines, first published in 2000, that said the illness could be treated with 28 days of antibiotics.

After reaching confidential settlements with the insurers, the plaintiffs filed a second amended complaint in January 2021, adding fraudulent and negligent misrepresentation claims against the IDSA and its panelists who wrote the guidelines. (See link for article)

__________________

SUMMARY:

  • A U.S. District Judge sided with the IDSA and dismissed the case
  • Although appealed, the IDSA convinced the appellate court to dismiss it as premature since the settlement hadn’t been finalized
  • The plaintiffs filed another appeal and a 3-judge panel of the 5th circuit heard arguments recently
  • The judge is leaning toward dismissing the lawsuit as it is about a scientific issue that needs a forum for debate
  • The challengers’ lawyer made the argument that more than 12 states have passed legislation to protect physicians’ ability to prescribe long-term treatment proving that in reality doctors are bound by IDSA “guidelines,” as well as the fact insurance companies hide behind these “guidelines” which have become mandates allowing them to deny payment for treatment

Category:

Activism, Lyme, Treatment

Novel Treatment For Relapsing Lyme, Babesia, and Bartonella

https://www.mdpi.com/2076-2607/11/9/2301

Comparison of the Efficacy of Longer versus Shorter Pulsed High Dose Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome with Bartonellosis and Associated Coinfections

by 1,2,*, 2 and Phyllis R. Freeman2
Microorganisms 2023, 11(9), 2301; https://doi.org/10.3390/microorganisms11092301
Received: 8 August 2023 / Revised: 27 August 2023 / Accepted: 8 September 2023 / Published: 12 September 2023
(This article belongs to the Special Issue Bartonella and Bartonellosis: New Advances and Further Challenges)

Abstract

Twenty-five patients with relapsing and remitting Borreliosis, Babesiosis, and bartonellosis despite extended anti-infective therapy were prescribed double-dose dapsone combination therapy (DDDCT), followed by one or several courses of High Dose Dapsone Combination Therapy (HDDCT). A retrospective chart review of these 25 patients undergoing DDDCT therapy and HDDCT demonstrated that 100% improved their tick-borne symptoms, and patients completing 6–7 day pulses of HDDCT had superior levels of improvement versus 4-day pulses if Bartonella was present.
At the completion of treatment, 7/23 (30.5%) who completed 8 weeks of DDDCT followed by a 5–7 day pulse of HDDCT remained in remission for 3–9 months, and 3/23 patients (13%) who recently finished treatment were 1 ½ months in full remission.
In conclusion, DDDCT followed by 6–7 day pulses of HDDCT could represent a novel, effective anti-infective strategy in chronic Lyme disease/Post Treatment Lyme Disease Syndrome (PTLDS) and associated co-infections, including Bartonella, especially in individuals who have failed standard antibiotic protocols.
_____________
For more:

Category:

Babesia, Bartonella, Lyme, research, Treatment

Peer-Reviewed Study Finds Routine HCQ Access May Have Prevented Over 520,000 Deaths. More COVID Masquerade: FREE Faulty Tests, Masks, and Fauci’s Back

https://popularrationalism.substack.com/p/deadly-policy-peer-reviewed

Deadly Policy: Peer-Reviewed Cross-Country Study Finds That Routine Hydroxychloroquine Access May Have Prevented Over 520,000 COVID-19 Deaths

Countries that restricted access to hydroxychloroquine had higher fatalities. National lockdowns had no effect on fatalities.

JAMES LYONS-WEILER
SEP 25, 2023

A comprehensive cross-country analysis to identify the factors affecting COVID-19 infections and fatalities found that lack of access to hydroxychloroquine was a major factor in driving COVID-19 deaths. The study, which was published today in the Public Health Policy Research section of the IPAK PHPI open-access journal, Science, Public Health Policy & the Law, controlled for other variables like obesity, urbanization, age, healthcare infrastructure, and policy responses such as lockdowns and travel restrictions.

A key finding of the studies included was a robust negative relationship between access to HCQ and COVID-19 fatalities. Countries that restricted access to hydroxychloroquine had higher fatalities. The analysis model resulted in an estimate that around 520,000 fatalities could have been avoided if HCQ had been made widely available in countries where it was restricted.

The study also found that obesity, older populations, fewer hospital beds, and less sunshine were associated with higher rates of infection and fatalities.  (See link for article)

A few points:

  • countries that restricted HCQ use should abandon their deadly policy.  (Please see: How a false HCQ narrative was created)
  • lockdowns were never significantly associated with lowered mortality rates
  • PCR testing was positively associated with reported infections, but not with fatalities, which the authors attribute to the high false positive rate of the use of non-quantitative PCR testing to assess COVID-19 diagnostic status
And speaking of horrific COVID testing:

The FREE COVID test which costs $600M for 200M of them, is being resurrected.  Despite the tests being fraudulent, inaccurate, contaminated and dangerous, citizens can get up to four “free” tests per household, paid for by insurers. 

These tests contain human protein-coding genes and often fail to amplify the viral target sequences causing FALSE NEGATIVES, but they have been manipulated to inflate cases which in turn has been used to drag out the ‘pandemic’ under false pretenses. The study above also shows they are associated with high false positives.  They also manipulated the tests on the “vaccinated” to make the shots look effective when they weren’t, and quit counting the flu to make everything look like COVID. The CDC has been overestimating flu deaths for two orders of magnitude to push the basically useless flu vaccines.

For a 5% prevalence rate for COVID infections in a population, the 42% false positive discovery rate means that for every 50 true positives, there will be 36 false positives.  Ponder that for a moment.

COVID CASES WILL BE OVERSTATED BY A FACTOR OF 72%

Due to unreliable PCR tests, there are no credible COVID “vaccine” data.
The CDC has a long history of insisting upon their own worthless tests that they own the patents on.

https://media.mercola.com/ImageServer/Public/2023/September/PDF/more-mask-masquerades-pdf.pdf

More Mask Masquerades

Analysis by Dr. Joseph Mercola

Sept. 22, 2023

STORY AT-A-GLANCE

  • Dr. Anthony Fauci is making the media rounds again, saying he hopes people will comply if mask recommendations return
  • In January 2021, the U.S. Centers for Disease Control and Prevention ordered the wearing of masks on public transportation. A court order issued in mid-April 2022 ultimately blocked enforcement of the order. So, it has now been legally clarified that the CDC cannot mandate anything. They can only make recommendations, which Fauci also recently confirmed
  • The 2023 Cochrane review of “Physical Interventions to Interrupt or Reduce the Spread of Respiratory Viruses” found masking had no effect on confirmed infection rates. The review also found no difference between medical/surgical masks and N95/P2 respirators
  • Yet in her February 2023 congressional testimony, then CDC director Dr. Rochelle Walensky argued the mask analysis only relied on a “small number” of trials as if more would somehow change the results and she falsely claimed the editor-in-chief had retracted the review summary.
  • Fauci is still doubling down on masking, saying masks work “on an individual level” even though randomized controlled trials show it makes no difference on the population level.  He could have ended all the controversy by funding large studies to draw more conclusive results, but he didn’t.  He also didn’t offer any studies to back up his claims, but in the past he has used low quality, observational & cross-sectional studies based on modeling.
  • There is plenty of evidence that masks cause harm and contain a dozen different volatile and potentially hazardous chemicals including graphene.
  • If mask recommendations are renewed this fall, do not comply
  • The asymptomatic spread narrative was completely destroyed by a Chinese study involving nearly 10 million people which showed that not a single case of COVID-19 could be traced to an asymptomatic individual who had tested positive. Still, the propaganda machine churned on, ignoring the evidence.
  • The pandemic of the “vaccinated” narrative was also blown apart.

Remember, mistakes and blunders were not made. Don’t let them get away with it. Refuse to comply.

 

Category:

research, Treatment, Viruses

Lyme Pain

https://danielcameronmd.com/lyme-pain/

LYME PAIN

Lyme pain

Welcome to another selection from my book “An Expert’s Guide on Navigating Lyme disease.” The books highlights the findings of my first 600 Lyme disease Science blogs.  In this episode, I will discuss Lyme pain.

By 

Reported pain associated with Lyme disease includes headaches, eye pain, neck pain, chest pain, abdominal pain, bladder pain, joint pain, and neuropathy. More recently, central sensitization syndrome (CSS) has been described. Pain medication may not be as effective as when used for other illnesses. Thankfully, pain often improves upon successfully treating Lyme disease.

CENTRAL SENSITIZATION SYNDROME AND LYME DISEASE.

Chronic pain, debilitating fatigue, and heightened sensory disturbances are common in Lyme disease patients. In the article “Post-Treatment Lyme Syndrome and Central Sensitization,” it is suggested that in some cases, such symptoms may be due to central sensitization syndrome (CSS) (Batheja et al., 2013). Central sensitization syndrome (CSS) involves changes in the central nervous system, particularly the brain and spinal cord. This syndrome “is thought to involve hyperactivation of central neurons, leading to various synaptic and neurotransmitter/ neuromodulator changes” (Batheja et al., 2013).

“Notably, in relation to Lyme disease, infections, in general, are known to activate central sensitization in some patients, possibly through the release of inflammatory cytokines,” Batheja points out. Read more.

LYME PRESENTING AS ABDOMINAL PAIN IN A BOY.

At age 8, a boy was hospitalized for severe abdominal pain and underwent extensive testing, but the results were negative. His abdominal pain remitted over the next two months (Savasta et al., 2020).

One year later, the boy was admitted with learning difficulties including attention deficit, difficulty speaking, irritability, and difficulty walking due to an ataxic gait.

He was diagnosed with abdominal neuroradiculopathy. Additional laboratory and radiological findings confirmed the diagnosis of late Lyme disease.

He was treated with six weeks of oral and IV antibiotics. Three months after treatment, the boy’s gait and scholastic performance had improved and entirely resolved after one year. Read more.

A WOMAN WITH A HISTORY OF LYME WITH PAIN REFRACTORY TO TREATMENT.

Lyme disease patients often suffer from ongoing illness following treatment. A study found that 31% of patients remained in significant pain for months after a three-week course of doxycycline to treat an erythema migrans rash (Bechtold et al., 2017).

Researchers describe a 31-year-old woman with Post-Treatment Lyme disease Syndrome (PTLDS) “whose pain was refractory to treatment options such as radiofrequency ablation, vitamin infusion therapy, opioid analgesics, and other pharmacotherapies.” Her pain began gradually, three years prior and a short time after being diagnosed and treated for Lyme disease. “The patient complained of diffuse body pain (6–7/10), fatigue, headache, and brain fog (7–8/10)” (Hanna et al. 2017).

The patient was prescribed off-label Ketamine for pain, reducing her pain by 71%. Read more.

BREAST CANCER PATIENT DEVELOPS LYME DISEASE.

A 61-year-old woman was diagnosed with stage II breast cancer with lymph node metastasis. She underwent a lumpectomy, followed by chemotherapy, radiation, and anti-estrogen treatment, letrozole.

One year later, the woman complained of radicular leg and back pain followed by a foot drop on one foot and right-sided facial palsy in two weeks. Moreover, she was in severe pain despite narcotics.

A spinal tap was performed due to unexplained neurologic findings. Lyme disease tests by blood and spinal fluid were positive.

She was diagnosed with Lyme disease and treated with intravenous ceftriaxone for 14 days. As a result, she became pain-free despite her history of severe pain despite narcotics. Read more.

LYME PRESENTING WITH SEVERE NEUROPATHIC PAIN.

A 36-year-old man suffered from a chronic pain syndrome associated with Post-Treatment Lyme Disease Syndrome (PTLDS) (Karri and Bruel, 2020). The doctors did not offer antibiotic treatment.

The patient described severe neuropathic pain in both feet and categorized the pain at a level 10 out of 10 despite treatment with methadone 5 mg every 4 hours as needed. The doctors assumed that the tick-borne infection had resolved, and elected not to treat it with antibiotics.

Instead, they treated the patient’s symptoms. The pain remained severe despite trials of gabapentin, duloxetine, bupropion, and narcotics. Two surgical procedures were performed, which improved the patient’s pain.

Author’s note: I might have retreated with an antibiotic. Read more.

LYME DISEASE CASE WITH SEVERE PAIN FOR 9 YEARS.

In an article published in Saudi Journal of Anaesthesia, doctors describe the case of a 23-year-old woman who suffered from severe chronic pain for 9 years due to post-treatment Lyme disease syndrome (PTLDS). Her pain intensified and became more difficult to manage after she underwent dental extractions and required hospitalization.

Out of 19 symptoms associated with Post-Treatment Lyme Disease Syndrome (PTLDS), 9 were especially significant and included fatigue, joint pain,  focusing/concentration, muscle pain, memory, finding words, sleep, neck pain, and irritability. The remaining symptoms were paresthesias (tingling sensations), low back pain, headache, photophobia, dizziness, visual clarity, chills, coordination, sweats, fasciculations (muscle twitches), breathing difficulties, urination changes, and nausea (Rebman et al., 2017).

Two participants met the criteria for postural orthostatic tachycardia syndrome (POTS). Results from the physical exam and laboratory testing of our sample of patients with PTLDS did not show a pattern of significant objective abnormalities.” However, “the most notable exception was the higher rate of diminished vibratory sensation on physical exam among participants with PTLDS. Read more.

LYME DISEASE PAIN AFTER DENTAL SURGERY.

Despite an uneventful extraction of four molars, a woman complained of severe widespread pain. Her pain medication list was extensive. The woman’s oral pain was minor, while her main issue was overall body pain (Lim and Kinjo Lim 2018).

Although the physicians used a multimodal pain regimen during surgery, they could not prevent her Lyme disease symptoms from recurring after surgery. Finally, the patient’s pain became so severe that she was transferred to the Intensive Care Unit (ICU). “A multimodal pain regimen was used for two days that include ketamine infusion, acetaminophen, ketorolac, oxycodone, and hydromorphone” (Lim and Kinjo Lim 2018).

Author’s note: It would be reasonable to revisit the woman’s PTLDS clinical history to determine whether she was adequately treated for her infection. Read more.

COMPLEX REGIONAL PAIN SYNDROME (CPRS) FROM LYME.

A review from Raigmore Hospital in the UK discussed autonomic dysfunction due to infectious diseases. “Complex regional pain syndromes [CRPS] and reflex sympathetic dystrophy (RSD) with regional sympathetic hyperactivity have also been reported in some patients with Lyme disease” (Artal 2017). CRPS is characterized by considerable pain (allodynia, hyperalgesia), edema, trophic changes of the skin and muscles, and sudomotor disorders.

Artal discussed a case first described by Sibanc et al. (2002). A 46-year-old man reported increasing pain and swelling in his left foot. The pain eventually caused his leg to become dysfunctional. “Even the slightest contact with the skin of the affected area caused the patient unbearable pain” (Sibanc and Lesnicar, 2002). The man improved after four weeks of intravenous ceftriaxone. Read more.

FATIGUE AND COGNITION FROM CENTRAL SENSITIZATION SYNDROME?

Fatigue and cognitive impairments are prominent features of central sensitization syndrome. Patients with Post-treatment Lyme disease Syndrome or chronic Lyme disease often have persistent insomnia and fatigue. While fatigue can have a central or peripheral origin, “central fatigue often has the significant correlate of cognitive impairment” (Batheja et al., 2013).

Studies of patients with Post-treatment Lyme disease Syndrome “have shown that problems with memory, working memory, processing speed, and verbal fluency are common” (Batheja et al., 2013).

Central sensitization syndrome has been described in several illnesses characterized by fatigue with similar presentations to Lyme disease, including fibromyalgia and chronic fatigue syndrome (Batheja et al., 2013). Read more.

For more:

Category:

Activism, Lyme, Pain Management, Treatment